A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment

Name: A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment
Published: 2017
License: Public Domain

AbbVie · 2017

ClinicalTrials.gov · Datasets · License: Public Domain · 2017

Open Source ↗

chronic-kidney-disease

hepatitis c virus (hcv), chronic hepatitis c virus, chronic kidney disease, glecaprevir, pibrentasvir, hepatitis c virus genotype, compensated cirrhosis, non-cirrhotic, interferon (ifn), treatment naïve, sofosbuvir (sof), pegylated interferon (pegifn)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 891720
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.